The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study conducted by researchers at
Read more
Home ยป
The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study conducted by researchers at
Read moreCDC panel endorses Pfizer vaccine for ages 12-15 NYU Langone COVID co-investigator Dr. Purvi Parikh weighs in on ‘Your World’ A new study released by
Read more